US$ 27.63
glp 1 and sibo semaglutide Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective GLP-1 for Weight Loss and
Description
While the precise reason has not yet been determined, its most likely a side effect of the weight loss itself, not the medication

Many people use GLP-1s to lose weight, treat type 2 diabetes, and/or manage other long-term health conditions

Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial

The parallel is striking
